Patents by Inventor Shawn Flanagan

Shawn Flanagan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Increasing Drug Bioavailability In Naltrexone Therapy
    Publication number: 20220233520
    Abstract: Disclosed are compositions, uses, methods and kits for increasing drug bioavailability in a naltrexone therapy.
    Type: Application
    Filed: April 11, 2022
    Publication date: July 28, 2022
    Applicant: Nalpropion Pharmaceuticals LLC
    Inventors: Shawn Flanagan, Eduardo Dunayevich
  • Increasing Drug Bioavailability In Naltrexone Therapy
    Publication number: 20220105087
    Abstract: Disclosed are compositions, uses, methods and kits for increasing drug bioavailability in a naltrexone therapy.
    Type: Application
    Filed: December 15, 2021
    Publication date: April 7, 2022
    Applicant: Nalpropion Pharmaceuticals LLC
    Inventors: Shawn Flanagan, Eduardo Dunayevich
  • Increasing Drug Bioavailability In Naltrexone Therapy
    Publication number: 20220088007
    Abstract: Disclosed are compositions, uses, methods and kits for increasing drug bioavailability in a naltrexone therapy.
    Type: Application
    Filed: June 9, 2021
    Publication date: March 24, 2022
    Applicant: Nalpropion Pharmaceuticals LLC
    Inventors: Shawn Flanagan, Eduardo Dunayevich
  • Increasing Drug Bioavailability In Naltrexone Therapy
    Publication number: 20190358222
    Abstract: Disclosed are compositions, uses, methods and kits for increasing drug bioavailability in a naltrexone therapy.
    Type: Application
    Filed: August 7, 2019
    Publication date: November 28, 2019
    Inventors: Shawn Flanagan, Eduardo Dunayevich
  • INCREASING DRUG BIOAVAILABILITY IN NALTREXONE THERAPY
    Publication number: 20130245056
    Abstract: Disclosed are compositions, uses, methods and kits for increasing drug bioavailability in a naltrexone therapy.
    Type: Application
    Filed: December 2, 2011
    Publication date: September 19, 2013
    Applicant: Orexigen Therapeutics, Inc.
    Inventors: Shawn Flanagan, Eduardo Dunayevich